December 23, 2021 (Reuters) – The U.S. on Thursday authorized Merck & Co’s (MRK.N) antiviral pill for COVID-19 for certain high-risk adult patients, a …
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept